Markus Vähä-Koskela

According to our database, Markus Vähä-Koskela authored at least 5 papers between 2018 and 2022.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2022

Using BERT to identify drug-target interactions from whole PubMed.

Jehad Aldahdooh, Markus Vähä-Koskela, Jing Tang, ZiaurRehman Tanoli

BMC Bioinform., 2022

Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments.

ZiaurRehman Tanoli, Jehad Aldahdooh, Farhan Alam, Yinyin Wang, Umair Seemab, Maddalena Fratelli, Petr Pavlis, Marián Hajdúch, Florence Bietrix, Philip Gribbon, Andrea Zaliani, Matthew D. Hall, Min Shen, Kyle R. Brimacombe, Evgeny Kulesskiy, Saarela Jani, Krister Wennerberg, Markus Vähä-Koskela, Jing Tang

Briefings Bioinform., 2022

2021

Exploration of databases and methods supporting drug repurposing: a comprehensive survey.

ZiaurRehman Tanoli, Umair Seemab, Andreas Scherer, Krister Wennerberg, Jing Tang, Markus Vähä-Koskela

Briefings Bioinform., 2021

2020

Interactive visual analysis of drug-target interaction networks using Drug Target Profiler, with applications to precision medicine and drug repurposing.

ZiaurRehman Tanoli, Zaid Alam, Aleksandr Ianevski, Krister Wennerberg, Markus Vähä-Koskela, Tero Aittokallio

Briefings Bioinform., 2020

2018

Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles.

ZiaurRehman Tanoli, Zaid Alam, Markus Vähä-Koskela, Balaguru Ravikumar, Alina Malyutina, Alok Jaiswal, Jing Tang, Krister Wennerberg, Tero Aittokallio

Database J. Biol. Databases Curation, 2018